Home > Research > Publications & Outputs > Cushing syndrome and disease

Electronic data

  • 2022McBridePhD

    Final published version, 4.55 MB, PDF document

    Available under license: CC BY-NC-ND: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

Text available via DOI:

View graph of relations

Cushing syndrome and disease: a study of the diagnosis, treatment, clinical consequences, and Health-related Quality of Life associated with these medical conditions

Research output: ThesisDoctoral Thesis

Published

Standard

Harvard

APA

Vancouver

Author

Bibtex

@phdthesis{0a2b5d9bbc5241a297028286c88219af,
title = "Cushing syndrome and disease: a study of the diagnosis, treatment, clinical consequences, and Health-related Quality of Life associated with these medical conditions",
abstract = "IntroductionCushing syndrome and disease are classified as rare diseases. The estimated incidence of CS (2021), was 10 to 15 per million people worldwide per year and can occur in any age group, mostly diagnosed in females with a median age of 41 years. The mortality rate is reported to be between 2-4 times higher than the general population. This study was conducted following my diagnosis of CS to compare other patients experiences of these medical conditions with my own, and the clinical consequences following a diagnosis and treatment of CS.MethodsA HRQoL survey was conducted on members of the Pituitary Associations using a disease-specific on-line questionnaire. Quantitative and Qualitative analysis was performed.Semi-structured interviews were also conducted on a range of Health Professions disciplines.ResultsThe study population was 86. The 71 female members median age was 42 and the 15 males was 39.4 years. The results showed a strong correlation between age and QoL scores, (rConclusionsThe wide clinical spectrum of CS produces medical dilemmas as symptoms vary and therefore patients can be sent to a range of Physicians prior to a definitive diagnosis. The prolonged consequences of excess cortisol affected my own and their HRQoL, even after remission, mainly due to the persistence of physical and neuropsychological morbidity. There remains a lack of psychological support and Health Professionals awareness. A patient{\textquoteright}s perspective should be recognised to be an integral part of the management of CS.",
author = "Margot McBride",
year = "2022",
doi = "10.17635/lancaster/thesis/1850",
language = "English",
publisher = "Lancaster University",
school = "Lancaster University",

}

RIS

TY - BOOK

T1 - Cushing syndrome and disease

T2 - a study of the diagnosis, treatment, clinical consequences, and Health-related Quality of Life associated with these medical conditions

AU - McBride, Margot

PY - 2022

Y1 - 2022

N2 - IntroductionCushing syndrome and disease are classified as rare diseases. The estimated incidence of CS (2021), was 10 to 15 per million people worldwide per year and can occur in any age group, mostly diagnosed in females with a median age of 41 years. The mortality rate is reported to be between 2-4 times higher than the general population. This study was conducted following my diagnosis of CS to compare other patients experiences of these medical conditions with my own, and the clinical consequences following a diagnosis and treatment of CS.MethodsA HRQoL survey was conducted on members of the Pituitary Associations using a disease-specific on-line questionnaire. Quantitative and Qualitative analysis was performed.Semi-structured interviews were also conducted on a range of Health Professions disciplines.ResultsThe study population was 86. The 71 female members median age was 42 and the 15 males was 39.4 years. The results showed a strong correlation between age and QoL scores, (rConclusionsThe wide clinical spectrum of CS produces medical dilemmas as symptoms vary and therefore patients can be sent to a range of Physicians prior to a definitive diagnosis. The prolonged consequences of excess cortisol affected my own and their HRQoL, even after remission, mainly due to the persistence of physical and neuropsychological morbidity. There remains a lack of psychological support and Health Professionals awareness. A patient’s perspective should be recognised to be an integral part of the management of CS.

AB - IntroductionCushing syndrome and disease are classified as rare diseases. The estimated incidence of CS (2021), was 10 to 15 per million people worldwide per year and can occur in any age group, mostly diagnosed in females with a median age of 41 years. The mortality rate is reported to be between 2-4 times higher than the general population. This study was conducted following my diagnosis of CS to compare other patients experiences of these medical conditions with my own, and the clinical consequences following a diagnosis and treatment of CS.MethodsA HRQoL survey was conducted on members of the Pituitary Associations using a disease-specific on-line questionnaire. Quantitative and Qualitative analysis was performed.Semi-structured interviews were also conducted on a range of Health Professions disciplines.ResultsThe study population was 86. The 71 female members median age was 42 and the 15 males was 39.4 years. The results showed a strong correlation between age and QoL scores, (rConclusionsThe wide clinical spectrum of CS produces medical dilemmas as symptoms vary and therefore patients can be sent to a range of Physicians prior to a definitive diagnosis. The prolonged consequences of excess cortisol affected my own and their HRQoL, even after remission, mainly due to the persistence of physical and neuropsychological morbidity. There remains a lack of psychological support and Health Professionals awareness. A patient’s perspective should be recognised to be an integral part of the management of CS.

U2 - 10.17635/lancaster/thesis/1850

DO - 10.17635/lancaster/thesis/1850

M3 - Doctoral Thesis

PB - Lancaster University

ER -